Stealth BioTherapeutics Inc.
29 clinical trials · Sponsor
◉ Watch Stealth BioTherapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) (NCT06373731) | Stealth BioTherapeutics Inc. | 2024-05-30 |
| Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) (NCT05162768) | Stealth BioTherapeutics Inc. | 2022-04-29 |
| ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA (NCT03891875) | Stealth BioTherapeutics Inc. | 2019-03-27 |
| A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension (NCT03323749) | Stealth BioTherapeutics Inc. | 2017-10-09 |
Track Stealth BioTherapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.